Please assess the completion status of the following clinical trial:

Trial Title: PRODIGY Registry in NYHA Class III Heart Failure Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Subject has given written informed consent~2. Male or female complex CCM eligible patients or equivalent and at least 18 years of age~3. Diagnosis of HF ≥ 3 months and NYHA Class III HF at the time of Screening~4. Subject fluent in English (written and oral) and with sufficient eyesight, hearing, and mental capacity to respond to the Cordella™ Heart Failure System audio/visual cues and operate the Cordella™ Heart Failure System~5. Subject has sufficient Cellular and/ or Wi- Fi Internet coverage at home~6. Subject agrees:~   1. that the treating Investigator is their solely complex CCM physician~  2. to return to the treating Investigator for all scheduled follow up visits and can return to the hospital for follow up~Exclusion Criteria:~1. Subjects enrolled in another investigational trial.~2. Subjects who are unwilling or deemed by the Investigator to be unwilling to comply with the study protocol, or subjects with a history of non-compliance~3. Severe illness, other than heart disease, which would limit survival to \<1 year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm (Type: None): Cordella™ Heart Failure System

Based on this trial design, predict the completion outcome and termination type (if applicable).